Adjuvant radiotherapy/chemoradiotherapy
infection
INFECTION, METASTASIS
In this trial, 14 patients received adjuvant radiotherapy/chemoradiotherapy after surgery, while 4 did not undergo radiotherapy due to the presence of unhealed wounds after surgery, and 4 more with postoperative pCR did not undergo radiotherapy based on comprehensive multidisciplinary team discussions and the patients’ wishes. 5 patients received adjuvant chemoradiotherapy due to the presence of IPR and risk factor of distant metastasis, other 9 patients received adjuvant radiotherapy. Adjuvant radiotherapy/chemoradiotherapy was given at 4-6 weeks after surgery, only one patient had an early termination of adjuvant radiotherapy due to infection of COVID-19 during radiotherapy.